DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
Dandan SongXiao-Sheng WangPublished in: Journal of translational medicine (2022)
DEPTH2 is expected to have a wider spectrum of applications in evaluating ITH in comparison to other algorithms.